Anelixis Therapeutics anelixistherapeutics.com


Public lists: Pharma Startups (4732)

Anelixis Therapeutics was formed in 2013 and is a for-profit subsidiary of ALS Therapy Development Institute (ALSTDI), a nonprofit biotechnology organization dedicated to developing effective treatments for ALS.

Anelixis Therapeutics was formed in 2013 and is a for-profit subsidiary of ALS Therapy Development Institute (ALSTDI), a nonprofit biotechnology organization dedicated to developing effective treatments for ALS.

Company (Alive / Active)

Phone: 617-441-7200

Fax:

300 Technology Square
Suite 400
Cambridge, 02130
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Anelixis Therapeutics $6.9M Apr 25, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Anelixis Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)